Attached files
file | filename |
---|---|
EX-32.1 - EX-32.1 - ABIOMED INC | abmd-ex321_9.htm |
EX-31.2 - EX-31.2 - ABIOMED INC | abmd-ex312_11.htm |
EX-31.1 - EX-31.1 - ABIOMED INC | abmd-ex311_10.htm |
EX-21.1 - EX-21.1 - ABIOMED INC | abmd-ex211_8.htm |
EX-10.19 - EX-10.19 - ABIOMED INC | abmd-ex1019_560.htm |
EX-10.18 - EX-10.18 - ABIOMED INC | abmd-ex1018_559.htm |
EX-10.17 - EX-10.17 - ABIOMED INC | abmd-ex1017_561.htm |
EX-4.2 - EX-4.2 - ABIOMED INC | abmd-ex42_13.htm |
EX-3.2 - EX-3.2 - ABIOMED INC | abmd-ex32_389.htm |
10-K - 10-K - ABIOMED INC | abmd-10k_20200331.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement Nos. 333-38865, 333-66029, 333-103245, 333-114066, 333-123675, 333-123676, 333-132054, 333-152989, 333-176620, 333-186613, 333-206395, 333-209414, 333-213319, and 333-227226 on Form S-8 of our reports dated May 21, 2020, relating to the financial statements of ABIOMED, Inc. and the effectiveness of ABIOMED, Inc.’s internal control over financial reporting appearing in this Annual Report on Form 10- for the year ended March 31, 2020.
/s/ Deloitte & Touche LLP
Boston, Massachusetts
May 21, 2020